Incidence of hepatocellular carcinoma in Southeast Iran

Hepatitis Monthly

Volumn 10, Issue 4, 2010, Pages 270-274

  Moghaddam, Sodaif Darvish ^a   Haghdoost, Ali Akbar ^b   Hoseini, Seyed Hamed ^c   Ramazani, Rashid ^d   Rezazadehkermani, Mohammad ^e  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^e Afzal Research Institute   (Iran)

Author keywords

Hepatocellular carcinoma; Incidence; Iran; Kerman

Indexed keywords

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; IRAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ONSET AGE; RISK FACTOR;

EID: 78649378681     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108.
2. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol. 2008;14(27):4300-8.
3. Parkin D, Whelan S, Ferlay J, Teppo L, Thomas D. Cancer Incidence in Five Continents Vol VIII. IARC Scientific publication No 155. Lyon: International Agency for Research on Cancer. 2002.
4. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2005;19(1):3-23.
5. Qian Y, Fan JG. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int. 2005;4(2):173-7.
6. Blum HE, Spangenberg HC. Hepatocellular carcinoma: an update. Arch Iran Med. 2007;10(3):361-71.
7. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med. 2000;3(4):192-201.
8. Alavian S, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon. 2008;8(4):281-94.
9. Alavian S, Adibi P, Zali M. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iranian Med. 2005;8(2):84-90.
10. Mousavi S, Alamolhoda A, Gouya M, Lickiss N. Implementation of Comprehensive National Cancer Control Program in Iran: an experience in a developing country. Annals of Oncology. 2008;19(2):398.
11. Hajarizadeh B. Systematic Review, Meta-analysis and modeling of Hepatitis B data in Iran for estimating Prevalenc and spacial distribution of Hepatitis B using GIS in 2001-2006. 2008[Unpuplished Data]
12. Aali B. The prevalence of HBsAg among pregnant women referred to Kerman maternity hospital in 1997. J Kerman Univ Med Sci. 1997;6:89-96.
13. Aminzade Z, Shabanishahrbabaky Z, Gachkar L. Frequency of HBsAg Positive in Pregnant Women Rafsanjan in Year 2003. J Rafsanjan Univ Med Sci and Health Services. 2004;3(2):126-33
14. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Risk factors for hepatocellular carcinoma in Southern Iran. Saudi medical journal. 2005;26(6):974-7.
15. Kao JH, Chen DS. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia. Liver Int. 2005;25(4):696-703.
16. Haghdoost A, Hosseini H, Chamani G, et al. Rising incidence of adenocarcinoma of the esophagus in Kerman, Iran. Arch Iran Med. 2008;11(4):364-70.
17. Cheraghali AM, Yazdanpanah H, Doraki N, et al. Incidence of aflatoxins in Iran pistachio nuts. Food Chem Toxicol. 2007;45(5):812-6.
18. Groopman JD, Kensler TW. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol Appl Pharmacol. 2005;206(2):131-7.